Evidence map›Paper›PMID 33434726›Full record

ArticleSchizophrenia research2021

Markers of copper transport in the cingulum bundle in schizophrenia.

Kirsten E Schoonover, Rosalinda C Roberts

Open access · greenAbstract read
In one paragraph

Article in Schizophrenia research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. The Potential of Hair Matrix for Biomarker Analysis in Schizophrenia.International journal of molecular sciences · 2025
    Review
  2. Review
  3. Genetic polymorphism and neuroanatomical changes in schizophrenia.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kirsten E SchoonoverDepartment of Psychology and Behavioral Neuroscience, University of Alabama at Birmingham, Birmingham, AL 35294, United States of America. Electronic address: schoonoverke@upmc.edu.
Rosalinda C RobertsDepartment of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL 35294, United States of America. Electronic address: rcusidor@uab.edu.
University of Alabama at Birmingham · US

Funding

White matter pathology in postmortem schizophrenia brainR21MH108867 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROBERTS, ROSALINDA C · 2016 to 2017
$404k
Mechanisms of copper dysregulation in schizophreniaR21MH117434 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROBERTS, ROSALINDA C · 2018 to 2019
$400k
Pyramidal neuron hypoactivity in schizophrenia cortexK00MH122943 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SCHOONOVER, KIRSTEN · 2019 to 2022
$339k
Mechanisms of Dysbindin Abnormalities in SchizophreniaF99NS105208 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHOONOVER, KIRSTEN · 2017 to 2018
$71k
NIMH NIH HHS K00 MH122943NIMH NIH HHS R21 MH108867NIMH NIH HHS R21 MH117434NINDS NIH HHS F99 NS105208
6 · The paper itself

Abstract

Imaging and postmortem studies indicate that schizophrenia subjects exhibit abnormal connectivity in several white matter tracts, including the cingulum bundle. Copper chelators given to experimental animals damage myelin and myelin-producing oligodendrocytes, and the substantia nigra of schizophrenia subjects shows lower levels of copper, copper transporters, and copper-utilizing enzymes. This study aimed to elucidate the potential role of copper homeostasis in white matter pathology in schizophrenia. Protein levels of the copper transporters ATP7A and CTR1, and dysbindin-1, an upstream modulator of copper metabolism and schizophrenia susceptibility factor, were measured using Western blot analyses of the postmortem cingulum bundle of schizophrenia subjects (n=16) and matched controls (n=13). Additionally, the patient group was subdivided by treatment status: off- (n=8) or on-medication (n=8). Relationships between proteins from the current study were correlated among themselves and markers of axonal integrity previously measured in the same cohort. Schizophrenia subjects exhibited similar protein levels to controls, with no effect of antipsychotic treatment. The dysbindin-1A/1BC relationship was positive in controls and schizophrenia subjects; however, antipsychotic treatment appeared to reverse this relationship in a statistically different manner from that of controls and unmedicated subjects. The relationships between dysbindin-1A/neurofilament heavy and ATP7A/α-tubulin were positively correlated in the schizophrenia group that was significantly different from the lack of correlation in controls. Copper transporters and dysbindin-1 appear to be more significantly affected in the grey matter of schizophrenia subjects. However, the relationships among proteins in white matter may be more substantial and dependent on treatment status.

Indexed as

Antipsychotic AgentsSchizophreniaWhite MatterCopperCopper Transporter 1Copper-Transporting ATPasesDysbindinHumansAntipsychotic AgentsATP7A protein, humanCopperCopper Transporter 1Copper-Transporting ATPasesDTNBP1 protein, humanDysbindinSLC31A1 protein, humanCopperDNTBP1DysbindinMyelinNeurofilament heavyWhite matterα-Tubulin

Identifiers

PMID33434726
PMCPMC7988290
OpenAlexW3119289629

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.